Lung Regeneration Using Amniotic Fluid Mesenchymal Stem Cells

Lung Regeneration Using Amniotic Fluid Mesenchymal Stem Cells Publisher Pubmed

Azargoon A¹ ; Negahdari B²

Source: Artificial Cells# Nanomedicine and Biotechnology Published:2018

Abstract

Respiratory diseases, such as chronic obstructive pulmonary disease (COPD), pulmonary hypertension and lung fibrosis, are yet a major challenge in the world and they result in irreversible structural lung damage. Lung transplantation as the only therapeutic option face some major challenges like graft rejection and cancer, arising as a result of immunosuppression. A low survival rate faced by lung transplantation patients is presently limited to approximately 5 years. Lungs shortage therefore calls for a mechanism that would increase the availability of suitable organs for transplantation. In this review, we give an update on the use of amniotic fluid mesenchymal stem cells (AFMSCs) as an optimal source for lungs scaffold re-cellularization, due to their limitless accessibility and possibility for proliferation and differentiation. Further studies will be required in tissue engineering (TE) and regenerative medicine (RM), especially shifting our focus towards AFMSCs as a cell source for this regeneration. © 2017 Informa UK Limited, trading as Taylor & Francis Group.

Related Docs

View other Related Docs

1. Lung Extracellular Matrix As a Platform for Lung Organ Bioengineering: Design and Development of Tissue Engineered Lung, Advances in Experimental Medicine and Biology (2021)

2. Lung Tissue Engineering and Preservation of Alveolar Microstructure Using a Novel Casting Method, Biotechnic and Histochemistry (2015)

3. Advances in Perinatal Stem Cells Research: A Precious Cell Source for Clinical Applications, Regenerative Medicine (2018)

Experts (# of related papers)

View all Related Experts

Abdolmohammad Kajbafzadeh (4)

Seyed Hadi Mousavi (2)

Style	Citing Format
MLA	Azargoon A, Negahdari B. "Lung Regeneration Using Amniotic Fluid Mesenchymal Stem Cells." Artificial Cells# Nanomedicine and Biotechnology, vol. 46, no. 3, 2018, pp. 447-451.
APA	Azargoon A, Negahdari B (2018). Lung Regeneration Using Amniotic Fluid Mesenchymal Stem Cells. Artificial Cells# Nanomedicine and Biotechnology, 46(3), 447-451.
Chicago	Azargoon A, Negahdari B. "Lung Regeneration Using Amniotic Fluid Mesenchymal Stem Cells." Artificial Cells# Nanomedicine and Biotechnology 46, no. 3 (2018): 447-451.
Harvard	Azargoon A, Negahdari B (2018) 'Lung Regeneration Using Amniotic Fluid Mesenchymal Stem Cells', Artificial Cells# Nanomedicine and Biotechnology, 46(3), pp. 447-451.
Vancouver	Azargoon A, Negahdari B. Lung Regeneration Using Amniotic Fluid Mesenchymal Stem Cells. Artificial Cells# Nanomedicine and Biotechnology. 2018;46(3):447-451.
BibTex	@article{ author = {Azargoon A and Negahdari B}, title = {Lung Regeneration Using Amniotic Fluid Mesenchymal Stem Cells}, journal = {Artificial Cells# Nanomedicine and Biotechnology}, volume = {46}, number = {3}, pages = {447-451}, year = {2018} }
RIS	TY - JOUR AU - Azargoon A AU - Negahdari B TI - Lung Regeneration Using Amniotic Fluid Mesenchymal Stem Cells JO - Artificial Cells# Nanomedicine and Biotechnology VL - 46 IS - 3 SP - 447 EP - 451 PY - 2018 ER -

Science Communicator Platform

Authors

Abstract